Publications by authors named "Jacob Bleesing"

14Publications

Four biomarkers linked to activation of CD8+ lymphocytes predict clinical outcomes in pediatric acute liver failure.

Hepatology 2020 Apr 15. Epub 2020 Apr 15.

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, School of Medicine and Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.31271DOI Listing
April 2020

Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation.

Pediatr Transplant 2020 05 12;24(3):e13695. Epub 2020 Mar 12.

Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.13695DOI Listing
May 2020

Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.

J Clin Immunol 2019 01 23;39(1):1-3. Epub 2018 Nov 23.

Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10875-018-0573-0
Publisher Site
http://dx.doi.org/10.1007/s10875-018-0573-0DOI Listing
January 2019

Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.

Clin Immunol 2018 12 24;197:219-223. Epub 2018 Oct 24.

Division of Bone Marrow Transplant, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216616183047
Publisher Site
http://dx.doi.org/10.1016/j.clim.2018.10.005DOI Listing
December 2018

Partial RAG deficiency in a patient with varicella infection, autoimmune cytopenia, and anticytokine antibodies.

J Allergy Clin Immunol Pract 2018 Sep - Oct;6(5):1769-1771.e2. Epub 2018 Feb 2.

Division of Pediatric Allergy & Immunology, Department of Pediatrics, University of South Florida, Tampa, Fla; Division of Pediatric Allergy Immunology, Massachusetts General Hospital for Children, Boston, Mass. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2018.01.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072614PMC
November 2019

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 NKG2A Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Front Immunol 2017 10;8:1244. Epub 2017 Oct 10.

Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fimmu.2017.01
Publisher Site
http://dx.doi.org/10.3389/fimmu.2017.01244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641412PMC
October 2017

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 NKG2A Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Front Immunol 2017 17;8:798. Epub 2017 Jul 17.

Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fimmu.2017.00
Publisher Site
http://dx.doi.org/10.3389/fimmu.2017.00798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511964PMC
July 2017

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2016 12 21;22(12):2220-2225. Epub 2016 Sep 21.

Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683393PMC
December 2016

A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.

Biol Blood Marrow Transplant 2016 11 16;22(11):2011-2018. Epub 2016 Aug 16.

Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.013DOI Listing
November 2016

The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.

Pediatr Transplant 2014 Feb 30;18(1):94-102. Epub 2013 Oct 30.

Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.12183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167786PMC
February 2014